Daewoong Pharma Says No Decision on Reported Sale of iN Therapeutics Control

• Daewoong Pharma has made no decision on subsidiary iN Therapeutics, responding to a Nov. 11, 2026, report about selling control.
• Multiple options remain under review; an update is due by Dec. 11, 2026, or when a decision is finalized.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daewoong Pharma published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261112800224), on November 12, 2026, and is solely responsible for the information contained therein.